Steve Schonfeld’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$788K Buy
+119,430
New +$784K ﹤0.01% 1752
2026
Q1
– Sell
-22,910
Closed -$283K – 2329
2025
Q4
$283K Buy
+22,910
New +$245K ﹤0.01% 1592
2025
Q2
– Sell
-213,861
Closed -$1.04M – 2156
2025
Q1
$1.04M Buy
213,861
+67,949
+47% +$562K 0.01% 1271
2024
Q4
$1.39M Buy
+145,912
New +$1.34M 0.01% 987
2024
Q1
– Sell
-27,200
Closed -$65.3K – 2145
2023
Q4
$65.3K Buy
+27,200
New +$63.9K ﹤0.01% 1653
2023
Q1
– Sell
-51,400
Closed -$607K – 2215
2022
Q4
$607K Buy
+51,400
New +$795K 0.01% 1421
2020
Q4
– Sell
-6,600
Closed -$682K – 1638
2020
Q3
$682K Buy
+6,600
New +$711K 0.01% 818
2020
Q2
– Sell
-8,376
Closed -$485K – 1313
2020
Q1
$485K Buy
+8,376
New +$483K 0.03% 593
2019
Q3
– Sell
-27,200
Closed -$1.32M – 1069
2019
Q2
$1.32M Buy
+27,200
New +$1.3M 0.05% 379
2018
Q3
– Sell
-12,000
Closed -$605K – 848
2018
Q2
$605K Buy
12,000
+6,009
+100% +$313K 0.03% 496
2018
Q1
$316K Buy
+5,991
New +$299K 0.02% 586

Other funds holding EBS

Steve Schonfeld's EBS Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Emergent Biosolutions (EBS) in Q3 2026: 119,430 shares worth $788K. The stake represents ﹤0.01% of the portfolio and ranks #1752 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in EBS as recently as Q4 2025.

Steve Schonfeld first reported a position in EBS in Q1 2018 and has held it in 11 quarters since. The position peaked at $1.39M in Q4 2024. 186 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Steve Schonfeld held 119,430 shares of Emergent Biosolutions worth $788K as of Q3 2026.
  • Emergent Biosolutions was a new Steve Schonfeld position in Q3 2026.
  • Emergent Biosolutions made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1752 holding.
  • Steve Schonfeld first reported a position in Emergent Biosolutions in Q1 2018 and has held it in 11 quarters since.
  • Steve Schonfeld's Emergent Biosolutions position peaked at $1.39M in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.